Using self-learning algorithms, DBL-4pen will bring most of the clinical improvement from DBLG1's closed-loop to insulin pen users, while the overall cost will be significantly lower for the payer.

Together with industrial partners, it is developing self-learning adaptive control systems that optimise the energy efficiency of the powertrain using smart sensors, cloud data and route information.